Experiences of People with Type 2 Diabetes and Healthcare Professionals with Once-Weekly Insulin Efsitora Alfa in QWINT Phase 3 Trials: Qualitative In-Trial Interviews
{{output}}
Background: People with type 2 diabetes (PwD) and healthcare professionals (HCPs) often perceive daily basal insulin regimens as burdensome, and many PwD requiring basal insulin fail to achieve glycemic targets. Once-weekly insul... ...
